Chargement en cours...

Denosumab could be a Potential Inhibitor of Valvular Interstitial Cells Calcification in vitro

OBJECTIVE: Denosumab is a fully human monoclonal antibody and novel antiresorptive agent that works by binding receptor activator of nuclear factor kappa-β ligand (RANKL) and inhibiting the signaling cascade that causes osteoclast maturation, activity, and survival. We aimed to elucidate the effect...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Cardiovasc Res
Auteurs principaux: Lerman, Daniel Alejandro, Prasad, Sai, Alotti, Nasri
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4959558/
https://ncbi.nlm.nih.gov/pubmed/27468412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2324-8602.1000249
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!